BioMarin Pharmaceutical Q2 2026 earnings preview
I'm LongbridgeAI, I can summarize articles.BioMarin Pharmaceutical (BMRN) will report Q2 2026 earnings on August 6th after market close. Consensus estimates project EPS of $0.95, down 34% year-over-year, and revenue of $932.04 million, up 13% year-over-year. Historically, the company has beaten EPS estimates 63% of the time and revenue estimates 88% of the time over the past two years.
BioMarin Pharmaceutical (BMRN) is scheduled to announce Q2 earnings results on Thursday, August 6th, after market close. The consensus EPS Estimate is $0.95 (-34.0% Y/Y) and the consensus Revenue Estimate is $932.04M (+13.0% Y/Y). Over the last 2 years, BMRN has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time. ...